Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Oxaloacetate + ascorbic acid** is a combination oral supplement composed of oxaloacetate (a metabolic intermediate involved in the citric acid cycle) and ascorbic acid (vitamin C), primarily developed to increase the stability and bioavailability of oxaloacetate for use in clinical applications. Oxaloacetate is known for its roles in glucose regulation, modulation of neurotransmitter balance (notably the GABA/glutamate ratio), and influence on metabolic and gene expression pathways. Ascorbic acid is included due to its capacity to improve oxaloacetate stability at room temperature, thereby enhancing the practical utility of the formulation. Clinical trials demonstrate this combination significantly improves emotional symptoms—such as depression, anxiety, perceived stress, aggression, and suicidal ideation—associated with premenstrual syndrome (PMS). Mechanistically, the enhanced stability of oxaloacetate allows it to exert biological effects potentially through both acute metabolic support and persistent gene expression modulation[1][3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on oxaloacetate + ascorbic acid.